Therapeutic Pipeline

From Data to Drug:
Real Assets

Accelerating discovery with QUAI Platform. We have secured validated candidates for Hair Loss and Sarcopenia.

Development Status

Code	Indication	Target/MoA	Phase
GOBT-101	Alopecia	AR & DHT Block	Lead Opt
GOBT-201 ↗	Sarcopenia	Apelin Pathway	Discovery

LEAD ASSET

Dual-action peptide therapeutics for Alopecia. Simultaneously blocking hair loss and
promoting regrowth via Wnt/β-catenin activation.

Target: AR & Wnt

Modality: Peptide